Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 64.95
+1.85 (2.93%)
Jul 29, 2025, 9:45 AM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 18.59 billion as of July 28, 2025. Its market cap has increased by 113.01% in one year.
Market Cap
18.59B
Enterprise Value
17.10B
Revenue
455.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
64.95
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 18.59B, an increase of 0.88%. That is a compound annual growth rate of 0.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 18.59B | 118.29% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 271.47B |
| Hansoh Pharmaceutical Group Company | 203.94B |
| JD Health International | 154.09B |
| Innovent Biologics | 152.40B |
| Akeso | 133.83B |
| WuXi Biologics | 128.18B |
| Sino Biopharmaceutical | 121.08B |
| CSPC Pharmaceutical Group | 98.67B |